ePrints
Items where Author is "Rybalka, E"
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 4.
Article
Gueven, N 
ORCID: 0000-0003-3782-767X, Ravishankar, P, Eri, RD ORCID: 0000-0003-1688-8043 and Rybalka, E 2021
, 'Idebenone: When an antioxidant is not an antioxidant'
, Redox Biology, vol. 38
, pp. 1-9
, doi: https://doi.org/10.1016/j.redox.2020.101812.
ORCID: 0000-0003-3782-767X, Ravishankar, P, Eri, RD ORCID: 0000-0003-1688-8043 and Rybalka, E 2021
, 'Idebenone: When an antioxidant is not an antioxidant'
, Redox Biology, vol. 38
, pp. 1-9
, doi: https://doi.org/10.1016/j.redox.2020.101812.
Kourakis, S, Timpani, CA, Campelj, DG, Hafner, P, Gueven, N ORCID: 0000-0003-3782-767X, Fischer, D and Rybalka, E 2021
, 'Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?'
, Orphanet Journal of Rare Diseases, vol. 16, no. 1
, pp. 1-9
, doi: https://doi.org/10.1186/s13023-021-01758-9.
ORCID: 0000-0003-3782-767X, Fischer, D and Rybalka, E 2021
, 'Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better?'
, Orphanet Journal of Rare Diseases, vol. 16, no. 1
, pp. 1-9
, doi: https://doi.org/10.1186/s13023-021-01758-9.
Kourakis, S, Timpani, CA, de Haan, JB, Gueven, N ORCID: 0000-0003-3782-767X, Fischer, D and Rybalka, E 2021
, 'Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy'
, Redox Biology
, doi: https://doi.org/10.1016/j.redox.2020.101803.
ORCID: 0000-0003-3782-767X, Fischer, D and Rybalka, E 2021
, 'Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy'
, Redox Biology
, doi: https://doi.org/10.1016/j.redox.2020.101803.
Timpani, CA, Goodman, CA, Stathis, CG, White, JD, Mamchaoui, K, Butler-Browne, G, Gueven, N ORCID: 0000-0003-3782-767X, Hayes, A and Rybalka, E 2020
, 'Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy'
, Scientific reports, vol. 10, no. 1
, pp. 1-18
, doi: https://doi.org/10.1038/s41598-020-57610-w.
ORCID: 0000-0003-3782-767X, Hayes, A and Rybalka, E 2020
, 'Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy'
, Scientific reports, vol. 10, no. 1
, pp. 1-18
, doi: https://doi.org/10.1038/s41598-020-57610-w.